Index^599
misalignment (bone fractures), 267
mitral insufficiency, 63–65
mitral stenosis, 65–67
mitral valve, 1, 3
mitral valve prolapse (MVP), 67–69
mole (trophoblastic disease), 517–518
monitoring patients after surgery, 483–484
mononucleosis, 159–160
motor neurons, 211
MRA (magnetic resonance angiography), 257
MRI (magnetic resonance imaging), 257, 279–280,
325–326
MS (multiple sclerosis), 237–240
multiple myeloma, 192–194
multiple sclerosis (MS), 237–240
muscles, 263
fibroids (leiomyomas), 507–508
testing potential (electromyography), 279
musculoskeletal system, 261–280
how it works, 262–263
map of, 261
carpal tunnel syndrome, 263–265
diagnostic tests, 277–280
arthrograph, 278
arthroscopy, 278
biopsy, 278
bone scan, 278–279
CT scans, 279
electromyography (EMG), 279
magnetic resonance imaging (MRI),
279–280
myelography, 280
ultrasound, 280
x-rays, 277
fractures (skeletal), 266–268
gout, 268–270
osteoarthritis, 271–273
osteomyelitis, 273–275
osteoporosis, 275–277
MVP (mitral valve prolapse), 67–69
myasthenia gravis, 240–243
myectomy, 28
myelin coating on nerve cells, 211, 237
myelogenous (myelocytic) leukemia,
189–191
myelography, 280
myeloma, multiple, 192–194
myocardial infarction (MI), 11–15
myocarditis, 41–42
myocardium, 26
myoclonic seizures, 253
myoglobin, 77
myxedema, 333–335N
Na.Seesodium
natriuretic peptides, 421
nausea, caused by anesthetic, 490
needle aspiration biopsy, 529
nephrolithiasis (kidney stones), 382–384
nephron, 374
nerve blocks, 482
nervous system, 209–257
how it works, 210–211
map of, 209
amyotrophic lateral sclerosis (ALS), 216–218
Bell’s palsy, 218–219
brain abscess, 218–221
brain tumor, 222–224
cerebral aneurysm, 225–227
diagnostic tests, 255–257
encephalitis, 227–229
Guillain-Barré syndrome, 230–232
head injury, 212–216
Huntington’s disease (chorea), 232–234
meningitis, 234–237
multiple sclerosis (MS), 237–240
myasthenia gravis, 240–243
Parkinson’s disease, 243–246
seizure disorder, 252–255
spinal cord injury, 246–249
stroke, 249–252
neurologic assessment after surgery, 483
neurons, 211
neuropathies, 542–544
neurotransmitters, 211, 453, 458
dopamine, 463
NHL (non-Hodgkin’s lymphoma), 153
NIDDM (non-insulin-dependent diabetes mellitus),
358–363
NMDA receptors, 463
non-Hodgkin’s lymphoma (NHL), 153
non-insulin-dependent diabetes mellitus (NIDDM),
358–363
non-small cell lung cancer, 110
nonatopic asthma, 93
nonunion (bone fractures), 267
norepinephrine, 333
overproduction (pheochromocytoma), 353–354
normotonic fluids, 420
nuclear cardiology, 74